Cullinan Oncology to Present Data Demonstrating Breadth and Progress of Its Immuno-Oncology Portfolio at AACR 2022
08.03.2022 - Five abstracts selected for poster presentation at the American Association for Cancer Research (AACR) Annual Meeting 2022 Data highlight progress on Cullinan Oncology’s pipeline of therapeutic candidates CLN-049 (Florentine), CLN-619 (MICA), ... Seite 1
Source: wallstreet-online.de